Sign in

CIK 0001867096

  • Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
871082097
Phone
+1 844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,678,894
in 11 filings, $1.7M under 10b5-1 plans

Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-01 KREHER NERISSA Director Grant or award +33,582 33,582
2026-07-01 KREHER NERISSA Director Grant or award · Stock Option (Right to Buy) +37,910 $8.00 $303K 37,910

Page 1 of 1 · 2 trades